Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.
Abdoulaye Sissoko, Astan Cissé, Clémence Duverdier...
https://pubmed.ncbi.nlm.nih.gov/39286963/Actively Recruiting
Led by Imagine Institute · Updated on 2026-09-09
3750
Participants Needed
25
Research Sites
N/A
Total Duration
The program GR-Ex, designated by the French Ministry of Higher Education and Research, focuses on improving understanding of how red blood cells, erythropoiesis, and iron metabolism work in both normal and disease states. It aims to develop innovative therapeutic approaches that offer meaningful advancements in treatment. This observational study involves collecting biological samples from patients with red blood cell disorders and their relatives to support research. Participants provide various biological samples including blood, saliva, urine, surgical remnants like skin or tumor tissue, and hair. Samples are collected both from affected patients and their non-affected relatives to help explore different aspects of red blood cell physiology and related diseases. The study is designed to run over many years to capture long-term data. Throughout the study, researchers will analyze multiple outcomes such as markers of spleen function, inflammation in sickle cell disease, hemolysis after artesunate treatment, and iron metabolism in specific anemias. They will also investigate the effects of treatments like phosphodiesterase inhibitors on cell adhesion and the removal of mitochondria during red blood cell formation. Participants may be involved in providing samples over extended periods, with ongoing monitoring to collect data relevant to these primary outcomes.
CONDITIONS
Pathophysiological Explorations of Red Blood Cells
S
Sandra Manceau, PhD
P
Pierre Buffet, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Imagine Institute
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 20 years
Participants provide biological samples such as blood, saliva, urine, and surgical tissues if available. Samples are also collected from relatives to support research on red blood cell physiology and diseases.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Abdoulaye Sissoko, Astan Cissé, Clémence Duverdier...
https://pubmed.ncbi.nlm.nih.gov/39286963/Yuhao Qiang, Abdoulaye Sissoko, Zixiang L Liu...
https://pubmed.ncbi.nlm.nih.gov/36730189/Imagine Institute
Lead Sponsor